FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today reported its financial results as of and for the three and nine months ended September 30, 2010. For the three months ended September 30, 2010, the Company reported a net loss of $7.8 million, or $0.29 per diluted share, compared to a net loss of $7.9 million, or $0.36 per diluted share, for the same period in 2009. For the nine months ended September 30, 2010, the Company reported a net loss of $23.9 million, or $1.02 per diluted share, compared to a net loss of $22.3 million, or $1.11 per diluted share, for the same period in 2009. The Company ended the quarter with $99.4 million of cash and cash equivalents and investments.
